StockTipsArenaBeta

BUY Divi's Laboratories Limited — Kavita Jain, Arihant Capital Markets

BUYDivi's Laboratories Limited

byKavita Jain, Arihant Capital MarketsHorizon: NA (inferred Swing (≤2wk))14 Jul 2026via CNBC Awaaz.

Entry₹7,130Inferred
Target₹7,350
Total upside +3.09% (call closed)
Stop loss₹6,950-2.52% risk
Exit₹7,35016 Jul 2026, 10:35 am
Target hit+3.09%0.00%upside left
Follow Kavita Jain for new calls(50% target hit, 52 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 2 active Swing calls on DIVISLAB

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 12:30 am IST
4 supporting2 neutral0 opposing
Supports the BUY call (4)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·16 Jul · today

1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced

NewsGoogle News·14 Jul · yesterday

(opens in new tab)

Divi's Laboratories Recommends ₹30 Final Dividend for FY26

NewsGoogle News·13 Jul · 2d ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·14 Jul · 2d ago

Neutral / worth noting (2)

Divis Laboratories reduces carbon footprint in FY 2025-26

NewsGoogle News·15 Jul · today

(opens in new tab)

Divis Laboratories fixes July 24 record date for ₹30 dividend

NewsGoogle News·15 Jul · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.